Investing
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)
Published:
These are some of the top pre-market analyst upgrades we are seeing this Wednesday morning:
- AMAG Pharmaceuticals (AMAG) Started as Overweight at JPMorgan
- Andersons (ANDE) Started as Outperform at Oppenheimer
- Bank of America (BAC) Raised to Market Perform at KBW
- BMC Software (BMC) Raised to Neutral at JPMorgan
- Cadence Design Systems (CDNS) Raised to Overweight at JPMorgan
- Citrix Systems (CTXS) Raised to Overweight at JPMorgan
- Inter Parfums (IPAR) Raised to Buy at Piper Jaffray
- Jefferies (JEF) Raised to Market Perform at KBW
- McDermott International (MDR) Started as Buy at American Tech Research
- Myriad Genetics (MYGN) Started as Outperform at Oppenheimer
- NuVasive (NUVA) Started as Overweight as JPMorgan
- Symantec (SYMC) Raised to Overweight at JPMorgan
Jon C. Ogg
October 8, 2008
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
